ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1358

Experiences and Attitudes Related to Assisted Reproductive Technologies Among Women with Systemic Rheumatic Disease

Sanjana Adurty1, Lucy Masto2, Amaya Smole2, Caroline Siegel2, Sarah Lieber3, Jonah Levine2, Bessie Stamm2, Lisa Mandl3, Michael Lockshin3, Medha Barbhaiya3 and Lisa Sammaritano3, 1Weill Cornell Medical College, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

Meeting: ACR Convergence 2023

Keywords: Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1345–1364) Reproductive Issues in Rheumatic Disorders Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic rheumatic disease (SRD) may be associated with decreased fertility. Advances in the safety and efficacy of oocyte cryopreservation (OOC) and other assisted reproductive technologies (ART) make these therapies increasingly appealing. However, few studies have assessed ART utilization among women with SRD. Here, we evaluate how sociodemographic factors and medical history influence OOC experiences and attitudes towards ART among women with SRD.

Methods: We enrolled women ages 18-65 seen ≥2 times by a Hospital for Special Surgery rheumatologist from 2020-2022 in the Rheumatology Women’s Reproductive Health and Wellness Cohort; cohort enrollment is ongoing. We included women aged 18-45 years with a self-reported SRD in this interim analysis. Using descriptive statistics, we assessed how sociodemographic factors, reproductive history, SRD, and rheumatology medications influence attitudes towards OOC. We also detailed the experiences of women who have undergone OOC, and we explored the relative importance of factors affecting decisions to use ART among women without previous fertility issues.

Results: Out of 815 cohort participants, 641 (79%) provided information on fertility; 265 were reproductive-aged with SRD. Of these, 21 (7.9%) had done OOC, and an additional 102 (38.5%) had contemplated OOC (Table 1). Openness to OOC was associated with no previous pregnancy (p< 0.01), greater infertility concern (p< 0.01), age< 30 (p=0.01), lack of a spouse/partner (p< 0.01), bachelor’s degree or higher (p=0.01), and use of antimalarials (p=0.04) or DMARDs/immunosuppressives (p=0.03). Previous use of other ART and age ≥40 were associated with either completing OOC or never having considered OOC (both p< 0.01). Of participants who had undergone OOC, most (81%) did so before 35 years of age (Table 2). Three women had complications related to OOC, all reporting SRD flares. For those who did not have fertility issues, 112 (64%) reported that, if necessary, they would consider ART only if their rheumatologist felt it was safe (Figure 1). This was the third most important factor influencing consideration of ART, preceded only by the participant or partner experiencing fertility problems.

Conclusion: Almost half of women with SRD in our cohort have either undergone or considered OOC for fertility preservation. Attitudes towards OOC were associated with pregnancy history, fertility concern, experience with other ART, age, marital status, education, and rheumatologic medications. Among women who have completed OOC, most initiated their cycles before age 35. Receiving their rheumatologists’ approval regarding the safety of ART is an important factor for many women who have not pursued ART. This analysis provides one of the first reports of OOC use in SRD. Our results highlight the significant role of SRD-related factors on attitudes towards and experiences with ART in women with SRD.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: S. Adurty: None; L. Masto: None; A. Smole: None; C. Siegel: UCB, 12, fellowship training is supported by UCB Women's Health Fellowship Program; S. Lieber: None; J. Levine: None; B. Stamm: None; L. Mandl: Annals of Internal Medicine, 12, Associate Editor, Regeneron Pharmaceuticals, 5, Up-to-Date, 9; M. Lockshin: None; M. Barbhaiya: None; L. Sammaritano: None.

To cite this abstract in AMA style:

Adurty S, Masto L, Smole A, Siegel C, Lieber S, Levine J, Stamm B, Mandl L, Lockshin M, Barbhaiya M, Sammaritano L. Experiences and Attitudes Related to Assisted Reproductive Technologies Among Women with Systemic Rheumatic Disease [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/experiences-and-attitudes-related-to-assisted-reproductive-technologies-among-women-with-systemic-rheumatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/experiences-and-attitudes-related-to-assisted-reproductive-technologies-among-women-with-systemic-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology